Clerveus Michael, Morandeira-Rivas Antonio, Moreno-Sanz Carlos, Herrero-Bogajo Maria Luz, Picazo-Yeste Joaquin Salvelio, Tadeo-Ruiz Gloria
Department of Surgery, "La Mancha Centro" General Hospital, Avd. de la Constitución nº 3. 13600, Alcázar de San Juan, Ciudad Real, Spain,
World J Surg. 2014 Aug;38(8):1937-46. doi: 10.1007/s00268-014-2535-x.
Single incision laparoscopic appendectomy (SILA) has been proposed as an alternative to conventional laparoscopic appendectomy (CLA).
The aim of this study was to evaluate the safety and efficacy of SILA when compared with CLA through a systematic review.
We performed an electronic search of EMBASE, PubMed, MEDLINE, and Cochrane Central Register of Controlled Trials. Randomized controlled trials (RCTs) that compared SILA with CLA were included.
Six RCTs met eligibility criteria, which included a total of 800 patients, 401 in the SILA group and 399 in the CLA group. There were no significant differences in terms of overall complications (odds ratio [OR] 0.93; 95% confidence interval [CI] 0.59-1.47; p = 0.77). SILA had a higher technical failure rate (OR 3.30; 95% CI 1.26-8.65; p = 0.01) and required a longer operative time (mean difference [MD] 4.67; 95% CI 1.76-7.57; p = 0.002). SILA was associated with better cosmetic results (standardized MD -0.4; 95% CI -0.64 to -0.16; p = 0.001) and earlier return to normal activity (MD -0.64; 95% CI -1.09 to -0.20; p = 0.005), although these advantages should be taken with caution due to the small number of studies reporting these two items and the short follow-up in the evaluation of cosmetic results. There were no significant differences in terms of postoperative pain or length of hospital stay between groups.
SILA is comparable to CLA in selected patients, although it is associated with a higher technical failure rate and longer operative time. Further randomized trials are needed to determine if SILA really offers benefits over CLA.
单孔腹腔镜阑尾切除术(SILA)已被提议作为传统腹腔镜阑尾切除术(CLA)的替代方法。
本研究旨在通过系统评价评估SILA与CLA相比的安全性和有效性。
我们对EMBASE、PubMed、MEDLINE和Cochrane对照试验中心注册库进行了电子检索。纳入比较SILA与CLA的随机对照试验(RCT)。
六项RCT符合纳入标准,共纳入800例患者,SILA组401例,CLA组399例。总体并发症方面无显著差异(优势比[OR]0.93;95%置信区间[CI]0.59 - 1.47;p = 0.77)。SILA的技术失败率更高(OR 3.30;95% CI 1.26 - 8.65;p = 0.01),且手术时间更长(平均差[MD]4.67;95% CI 1.76 - 7.57;p = 0.002)。SILA与更好的美容效果相关(标准化MD -0.4;95% CI -0.64至-0.16;p = 0.001)以及更早恢复正常活动(MD -0.64;95% CI -1.09至-0.20;p = 0.005),不过由于报告这两项内容的研究数量较少且美容效果评估的随访时间较短,这些优势应谨慎看待。两组在术后疼痛或住院时间方面无显著差异。
在特定患者中,SILA与CLA相当,尽管其技术失败率更高且手术时间更长。需要进一步的随机试验来确定SILA是否真的比CLA更具优势。